1.Авдеев, С. Н. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19) / С. Н. Авдеев, Л. В. Адамян, Е. И. Алексеева [и др.] / Временные методические рекомендации. Версия 15 от 22.02.2022. –М., 2022. –245 с.2.Арсентьева, Н. А. Цитокины в плазме крови больных COVID-19 в острой фазе заболевания и фазе полного выздоровления / Н. А. Арсентьева, Н. Е. Любимова, О. К. Бацунов [и др.] // Мед. иммунол. –2021. –Т. 3, No 3. –С. 311–326.3.Карпова, Л. С. Территориально-временное распространение COVID-19 в мире в начале пандемии 2020 года / Л. С. Карпова, Д. А. Лиознов, К. А. Столяров [и др.] // Эпидемиология и вакцинопрофилактика. –2021. –Т. 20, No 4. –С. 19–27.4.Лобзин, Ю. В. Медицинская реабилитация детей, перенесших COVID-19 / Ю. В. Лобзин, И. В. Черкашина, И. Г. Самойлова / Журн. инфектол. –2020.–Т. 12, No. 3. –С. 64–74.5.Лукашев, А. Н. COVID-19: год вместе / А. Н. Лукашев // Журн. инфектол. –2021.–Т. 13, No. 1. –С. 5–12.6.Налетов А.В., Каспир Д.В., Курышева О.А. Патогенетические основы постковидного синдрома раздраженного кишечника (обзор литературы)//Вестник неотложной и восстановительной хирургии. 2021. Т. 6. No 4. С. 114-120. 7.Османов И.М., Солодовникова О.Н., Борзакова С.Н., Сбродова Т.В., Ильясова П.Н., Новоселова С.Н. Поражение пищеварительного тракта как проявление c0vid-19 у ребенка 4 лет//Доктор.Ру. 2021. Т. 20. No 3. С. 56-59. 8.Платонова, Т. А. Особенности формирования гуморального иммунитета у лиц с различными клиническими проявлениями COVID-19 / Т. А. Платонова, А. А. Голубкова, Е. А. Карбовничая, С. С. Смирнова // Эпидемиология и вакцинопрофилактика. –2021.–Т. 20, No 1. –С. 20–25.9.Пшеничная, Н. Ю. COVID-19 –новая глобальная угроза человечеству / Н. Ю. Пшеничная, Е. И. Веселова, Д. А. Семенова [и др.] //Эпидемиология и инфекционные болезни. Актуальные вопросы. –2020. –No 1. –С. 6–13. 10.Ратникова А.К., Гриневич В.Б., Козлов К.В., Кравчук Ю.А., Арапханова М.М., Кащенко В.А., Ратников В.А. Новая коронавирусная инфекция covid-19: роль желудочно-кишечного тракта в патогенезе заболевания//Медицинский вестник Башкортостана. 2021. Т. 16. No 5 (95). С. 63-76.11.Хавкина, Д. А. Роль дезинтоксикационной и антиоксидантной терапии в лечении COVID-19: теория и практика / Д. А. Хавкина, Т. А. Руженцова, П. В.123 Чухляев [идр.] // Эпидемиология и инфекционные болезни. Актуальные вопросы. –2020. –No 2. –С. 62–69.12.Янушевич, О. О. Распространенность и прогностическое значение гастроэнтерологических проявлений COVID-19: Данные Российской университетской клиники / О. О. Янушевич, И. В. Маев, Н. И. Крихели [и др.] / Тер. архив. –2021. –Т. 93, No8. –С. 853–861.13.Akkus, C. Development of pancreatic injuries in the course of COVID-19 / C. Akkus, H. Yilmaz, S. Mizrak [et al.] // Acta Gastroenterol. Belg. –2020. –Vol. 83, No 4. –P. 585–592.14.Alharbi KS, Singh Y, Hassan Almalki W, Rawat S, Afzal O, Alfawaz Altamimi AS, Kazmi I, Al-Abbasi FA, Alzarea SI, Singh SK, Bhatt S, Chellappan DK, Dua K, Gupta G. Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora. Chem Biol Interact. 2022 May 1;358:109898. doi: 10.1016/j. cbi.2022.109898.15.An EUA for casirivimab and imdevimab for COVID-19 // Med. Lett. Drugs Ther. –2020. –Vol. 62, No 1614. –P. 201–202.16.Anaya JM, Rojas M, Salinas ML, Rodríguez Y, Roa G, Lozano M, Rodríguez-Jiménez M, Montoya N, Zapata E; Post-COVID study group, Monsalve DM, AcostaAmpudia Y, Ramírez-Santana C. Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. 2021 Nov;20(11):102947. doi: 10.1016/j.autrev.2021.102947. 17.Aziz, M. The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis / M. Aziz, R. Fatima, W. Lee-Smith, R. Assaly // Crit. Care. –2020. –Vol. 24, No 1. –P. 255. 18.Bacaksız F, Ebik B, Ekin N, Kılıc J. Pancreatic damage in COVID-19: Why? How? Int J Clin Pract. 2021 Oct;75(10): e14692. doi: 10.1111/ijcp.14692.19.Balmant BD, Torrinhas RS, Rocha IM, Fonseca DC, Formiga FFC, Bonfá ESDO, BorbaEF, Waitzberg DL. SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link? Nutrition. 2021 May;85:111115. doi: 10.1016/j.nut.2020.111115.20.Bortolato B, Carvalho AF, Soczynska JK, Perini GI, McIntyre RS. Te Involvement of TNF-αin Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specifc Treatments. Curr Neuropharmacol. 2015;13(5):558–76. doi: 10.2174/15701 59x13666150630171433.21.Brüssow, H. Problems with the concept of gut microbiota dysbiosis / H. Brüssow // Microb. Biotechnol. –2020. –Vol. 13, No 2. –P. 423–434. 22.Caruso, D. Quantitative chest CT analysis in discriminating COVID-19 from non-COVID-19 patients / D. Caruso, M. Polici, M. Zerunian [et al.] // LaRadiolologia Medica. –2021. –Vol. 126, No 2. –P. 243-249.23.COVID-19 rapid guideline: managing the long-term effects of COVID-19 NICE guideline [NG188] Published date:18 December 2020]. Available at: https://www.nice. org.uk/guidance/ng188(Access: 01.10.2022)24.Davies, N. G. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England / N. G. Davies, S. Abbott, R. C. Barnard [et al.] // Science. –2021. –Vol. 372, No 6538: eabg3055.25.Effenberger M, Grabherr F, Mayr L, et al. Faecal calprotectin indicates intestinal inflammation in COVID-19.Gut. 2020 Aug;69(8):1543–1544. doi: 10.1136/gutjnl-2020–321388.26.Fang, L.G. Remarkable gastrointestinal and liver manifestations of COVID-19: a clinical and radiologic overview / L. G. Fang, Q. Zhou // World J. Clin. Cases. –2021. –Vol. 9, No 16. –P. 4969–4979.27.Gao, Y. A brief review of monoclonal antibody technology and its representative applications in immunoassays / Y. Gao, X. Huang, Y. Zhu, Z. Lv // J. Immunoassay. Immunochem. –2018. –Vol. 39, No 4. –P. 351–364.28.Grasselli, G. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy / G. Grasselli, A. Zangrillo, A. Zanella[et al.] // JAMA. –2020. –Vol. 323, No 15. –P.1574–1581.29.Grusova, G. Pancreatic injury in patients with SARS-Cov-2 (COVID-19) infection: a retrospective analysis of CT findings // G. Grusova, R. Bruha, B. Bircakova [et al.] // Gastroenterol. Res. Pract.–2021: 5390337.30.Hashimoto T, Perlot T, Rehman A, Trichereau J, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012 Jul 25;487(7408):477–81. doi: 10.1038/nature11228. 31.Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ter. 2020 Jun 4;12(1):69. doi: 10.1186/s13195–020–00640–3.44 экспериментальнаяиклиническаягастроэнтерология| No 208 (12) 2022 experimental & clinical gastroenterology | No 208 (12) 2022 32.International Statistical Classifcation of Diseases and Related Health Problems 10th Revision (ICD-10) (https://33.Janiri D, Kotzalidis GD, Giuseppin G, Molinaro M, Modica M, Montanari S, Terenzi B, Carfì A, Landi F, Sani G; Gemelli Against COVID-19 Post-acute Care Study Group. Psychological Distress Afer Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service. Front Psychiatry. 2020 Nov 12;11:590135. doi: 10.3389/ fpsyt.2020.59013534.Jin, J.-M. Gender differences in patients with Covid-19: focus on severity and mortality / J.-M. Jin, P. Bai, W. He [et al.] // Front. Public Health. –2020. –Vol. 8, No 1. –P. 152.13135.Kazemian N, Kao D, Pakpour S. Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic. Int J Mol Sci. 2021 Mar 16;22(6):3004. doi: 10.3390/ ijms22063004.36.Kordzadeh-Kermani, E. Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19) / E. Kordzadeh-Kermani, H. Khalili, I. Karimzadeh // Future Microbiol. –2020. –Vol. 15, No 5. –P.1287–1305. 37.Kumaran NK, Karmakar BK, Taylor OM. Coronavirus disease-19 (COVID-19) associated with acute necrotising pancreatitis (ANP). BMJ Case Rep. 2020 Sep 7;13(9):e237903. doi: 10.1136/bcr-2020–237903.38.Kunutsor, S.K. Markers of liver injury and clinical outcomes in COVID-19 patients: a systematic review and metaanalysis / S.K. Kunutsor, J.A. Laukkanen // J. Infect. –2021. –Vol. 82, No 1. –P. 159–198.13239.Lamprecht B. Gibt es ein Post-COVID-Syndrom? [Is there a post-COVID syndrome?]. Pneumologe (Berl). 2020;17(6):398–405. German. doi: 10.1007/s10405–020–00347–0.40.Lazebnik L. B., Golovanova E. V., Alekseenko S. A., et al. Recommendations for the prevention and treatment of esophago-gastro-entero-colopathy induced by nonsteroidal antiinflammatory drugs “NSAID”. Experimental and Clinical Gastroenterology. 2018;(3):4–18. (In Russ.) 41.Liang L, Yang B, Jiang N, Fu W, He X, Zhou Y, Ma WL, Wang X. Tree-month Follow-up Study of Survivors of Coronavirus Disease 2019 afer Discharge. J Korean Med Sci. 2020 Dec 7;35(47): e418. doi: 10.3346/jkms.2020.35. e418.42.Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC, Ng SSS, Zhang F, Li AYL, Lu W, Hui DS, Chan PK, Chan FKL, Ng SC. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022 Mar;71(3):544–552. doi: 10.1136/gutjnl-2021–325989.43.Lv L, Jiang H, Chen Y, GuS, Xia J, Zhang H, Lu Y, Yan R, Li L. Te faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes. Anal Chim Acta. 2021 Apr 1;1152:338267. doi: 10.1016/j.aca.2021.338267.44.Nersesjan V, Fonsmark L, Christensen RHB, Amiri M, Merie C, Lebech AM, Katzenstein T, Bang LE, Kjærgaard J, Kondziella D, Benros ME. Neuropsychiatric and Cognitive Outcomes in Patients 6 Months Afer COVID-19 Requiring Hospitalization Compared With Matched Control Patients Hospitalized for Non-COVID-19 Illness. JAMA Psychiatry. 2022 May 1;79(5):486–497. doi: 10.1001/jamapsychiatry.2022.0284.45.Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A. Hepatic consequences of COVID-19 infection. Lapping or biting? Eur J Intern Med. 2020 Jul;77:18–24. doi: 10.1016/j.ejim.2020.05.03.46.Shi, H. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study / H. Shi, X. Han, N. Jiang [et al.] // Lancet Infect. Dis. –2020. –Vol. 20, No 4. –P. 425–434.47.Shih AR, Misdraji J. COVID-19: gastrointestinal and hepatobiliary manifestations. Hum Pathol. 2022 Jul 16: 0046–8177(22)00179–4. doi: 10.1016/j.humpath.2022.07.006.48.Tabatabaei, S. M. H. Chest CT in COVID-19 pneumonia: what are the findings in mid-term follow-up? / S. M. H. Tabatabaei, H. Rajebi, F. Moghaddas [et al.] // Emer. Radiol. –2020. –Vol. 27, No 6. –P. 711–719.49.Tang, X. On the origin and continuing evolution of SARS-CoV-2 / X. Tang, C. Wu, X. Li [et al.] // Nat. Sci. Rev. –2020. –Vol. 7, No 6. –P. 1012–1023. 196. Wang, S. A deep learning algorithm using CT images to screen for Corona virus disease (COVID-19) / S. Wang, B. Kang, J. Ma [et al.] // Eur. Radiol. –2021. –Vol. 31, No 8. –P. 6096–6104.50.Wong YJ, Tan M, Zheng Q, Li JW, Kumar R, Fock KM, Teo EK, Ang TL. A systematic review and meta-analysis of the COVID-19 associated liver injury. Ann Hepatol. 2020 Nov-Dec;19(6):627–634. doi: 10.1016/ j. aohep. 2020.08.064. 51.Zhou, Z. Effect of gastrointestinal symptoms in patients with COVID-19 / Z. Zhou, N. Zhao, Y. Shu [et al.] // Gastroenterology. –2020. –Vol. 158, No 8. –P.2294.